Quanyin Hu

30PUBLICATIONS
28CO-AUTHORS
Separation technologiesBiomaterialsPharmaceutical delivery technologiesHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 31, 2026
Macropinocytosis-mediated recyclable LYTACs (McR-TACs) for receptor-independent protein degradation.

|Aug 11, 2026
Engineering Antibodies into Targeted Chimeras: From Recognition Modules to Programmable Degraders.

|Mar 30, 2026
Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation.

Xinchen Lu, Quanyin Hu

|Feb 06, 2026
Engineering platelets as cancer therapeutics.

Yu Chen, Tyler Wolter, Zhen Gu

|Dec 18, 2025
Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery.

Yixin Wang, Edikan Ogunnaike, Huan Yang

|Sep 24, 2025
Rational design of the linkers in targeting chimeras.

Yiping Duan, Michelle Y Cai, Jinyi Xu

Pageof 5

Frequent Collaborators

8 joint publications

Zhaoting Li

7 joint publications

Yu Chen

5 joint publications

Sichen Yuan

3 joint publications

Tyler Wolter